IGS GeboJagema has formed a strategic partnership with BC Partners to support its growth in the medical device tooling market, allowing for expanded capabilities and market opportunities.

Target Information

IGS GeboJagema (IGS) is a leading independent manufacturer in the precision tooling market for medical devices, known for its complex, high-precision moulds utilized in the production of critical medical devices such as drug delivery systems, contact lenses, diagnostic equipment, and healthcare consumables. With a strong reputation built over decades of specialized expertise, IGS serves as a key strategic partner to top global healthcare and pharmaceutical companies. Headquartered in Eindhoven, the Netherlands, IGS has expanded its presence into the United States with a facility in Peachtree City, Georgia, and aims to leverage its exceptional market position to pursue growth in emerging healthcare sectors, particularly the GLP-1 segment.

The strategic partnership with BC Partners, along with continued involvement from current financial partner Smile Invest and IGS's management, positions the company for future success. IGS will retain a minority stake while ensuring the exit of Rabo Private Equity, which previously held a minority interest.

Industry Overview

The healthcare sector in the Netherlands stands out as one of the most advanced in Europe, characterized by extensive research and development alongside a robust manufacturing base. The country is home to numerous pharmaceutical and medical